FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/09/2025
Back to search
Official data from USPTO
KIDNEY PYJAMAS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
KIDNEY PYJAMAS
ST13
US500000079375222Class
5, 10, 42
Filing
79375222
Registration
7574735
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 10, 42
Filing date
03/30/2023
Registration date
11/26/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/26/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
AGREDA, SAMANTHA LEIGH
Law office
N50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
IISHIELD PTY LTD
Representatives
Jennifer A. Visintine Thompson Coburn LLP
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Renal scanning agents for medical use being pharmaceutical preparations for use in ex-vivo and in-vivo diagnosis of kidney disorders; renal scanning agents for medical use being pharmaceutical preparations for use in in-vivo diagnosis of kidney disorders; in-vivo and ex-vivo diagnostic materials for medical use being pharmaceutical preparations for the diagnosis of kidney disorders; diagnostic testing materials for medical use being pharmaceutical preparations for use in the diagnosis of kidney disorders; in-vivo diagnostic materials for medical use being pharmaceutical preparations for use in the diagnosis of kidney disorders; in-vivo and ex-vivo diagnostic preparations for medical use being pharmaceutical preparations for use in the diagnosis of kidney disorders; diagnostic preparations for medical use in-vivo diagnosis being pharmaceutical preparations for use in the diagnosis of kidney disorders; in-vivo and ex-vivo radiodiagnostic agents for medical use being pharmaceutical preparations for use in the radiodiagnosis of kidney disorders; diagnostic scanning agents for in-vivo use being pharmaceutical preparations for use in the diagnosis of kidney disorders; in vivo medical diagnostic scanning agents for medical use being pharmaceutical preparations for use in the diagnosis of kidney disorders; pharmaceutical preparations for the preservation and storage of human organs between transplant surgeries; pharmaceutical preparations for the preservation and storage of human organs; solutions for medical use being pharmaceutical preparations for use in the preservation of organs between transplant surgeries; solutions for medical use being pharmaceutical preparations for use in the storage of organs between transplant surgeries
Class 10
medical supports for the bodya medical sheath for the encasement of donor transplant organs during storage and transportation; medical supports for the bodya medical sheath for the encasement of donor transplant organs during transplantation surgery; surgical apparatus for use in transplant surgerya medical sheath for the encasement of donor transplant organs during storage and transportation; surgical implants comprised of artificial materials; medical apparatus and instruments for the purposes of long-term graft survival during organ transplant surgery; medical apparatus and instruments for the purposes of short-term graft preservation during organ transplant surgery
Class 42
Research and development of technology in the field of maintenancepreservationtransportation and storage of organs in-vivo and ex-vivo; research and development of new products for others; scientific research to develop new products; scientific research into the development of new products; technical research into the development of new products; medical research services in relation to maintaining and improving the quality of organs in-vivo and ex-vivo; medical and pharmacological research services; medical researchanalysis of tissues for medical research; medical and scientific researchconducting clinical trials for others; medical research; scientific research for medical purposes; pharmacological research not for medical purposesconducting pharmacological testing on organs and body parts in-vivo and ex-vivo; advisory services relating to pharmacology; consultancy pertaining to pharmacology; medical and scientific researchconducting clinical trials for others; providing information about medical and scientific research in the field of pharmaceuticalsclinical trials and organ transplant surgeries; providing scientific research information and information about new product designincluding online; scientific research consultancy in the field of pharmaceuticalsclinical trials and organ transplant surgeries; scientific research
Publications
History of USPTO decisions and trademark events.
32 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/22/2025
FIMP
FINAL DISPOSITION PROCESSED
04/22/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/26/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/10/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/25/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/25/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/26/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
11/26/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/24/2024
PUBO
PUBLISHED FOR OPPOSITION
09/24/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/19/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/17/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/17/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/17/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/15/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/15/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/15/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/15/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/15/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/15/2024
RFNT
REFUSAL PROCESSED BY IB
02/06/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/18/2024
RFRR
REFUSAL PROCESSED BY MPU
01/18/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/30/2023
CNRT
NON-FINAL ACTION WRITTEN
12/29/2023
DOCK
ASSIGNED TO EXAMINER
12/26/2023
MAFR
APPLICATION FILING RECEIPT MAILED
08/15/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/11/2023
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
08/10/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/27/2023
Continuous trademark protection
Get notified about every new filing that threatens KIDNEY PYJAMAS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.